The haloperidol story

Annals of Clinical Psychiatry

Volumn 17, Issue 3, 2005, Pages 137-140

  Granger, Bernard ^a   Albu, Simona ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Butyrophenones; Haloperidol; History; Paul Janssen

Indexed keywords

BUTYROPHENONE DERIVATIVE; CHLORPROMAZINE; DEXTROMORAMIDE; HALOPERIDOL; METHADONE; NEUROLEPTIC AGENT; PETHIDINE; PROPIOPHENONE;

DELUSION; DRUG EFFECT; FRANCE; HALLUCINATION; HISTORY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SYNTHESIS; TRANQUILIZING ACTIVITY; UNITED STATES;

ANIMALS; ANTIPSYCHOTIC AGENTS; BELGIUM; BUTYROPHENONES; FRANCE; HALOPERIDOL; HISTORY, 20TH CENTURY; HUMANS; SCHIZOPHRENIA; UNITED STATES;

EID: 23844482748     PISSN: 10401237     EISSN: 15473325     Source Type: Journal    
DOI: 10.1080/10401230591002048     Document Type: Review

References (14)

1. Niemegeers CJE: Paul Janssen and the discovery of haloperidol and other neuroleptics. Beerse: Janssen Research Foundation, 1988
2. Janssen PAJ: The butyrophenone story. In: Ayd FJ Jr, ed. Janssen research in psychiatry. Baltimore: Ayd Medical Communications, 1989:9-23
3. Granger B: La découverte de l'halopéridol. L'Encéphale 1999; 25(1):59-66
4. Janssen PAJ, Van de Westeringh C, Jageneau AHM, Demoen PJA, Hermans BKF, Van Daele GHP, Schellekens KHL, Van der Eycken CAM, Niemegeers CJE: Chemistry and pharmacology of compounds related to 4-(4-hydroxy-4-phenyl-piperidino)- butyrophenone. Part I. Synthesis and screening data in mice. J Med Pharm Chem. 1959; 1(3):281-97
5. Janssen PAJ, Niemegeers CJE: Chemistry and pharmacology of compounds related to 4-(4-hydroxy-4-phenyl-piperidino)-butyrophenone. Part II. Inhibition of apomorphine vomiting in dogs. Arzneimittel-Forschung 1959; 9:765-7
6. Janssen PAJ, Niemegeers CJE, Schellekens KHL: Chemistry and pharmacology of compounds related to 4-(4-hydroxy-4-phenyl-piperidino)-butyrophenone. Part III. Duration of antiemetic action and oral effectiveness of haloperidol (R 1625 and of chlorpromazine in dogs. Arzneimittel-Forschung 1960; 10:955-58
7. Janssen PAJ, Jageneau AHM, Schellekens KHL: Chemistry and pharmacology of compounds related to 4-(4-hydroxy-4-phenyl-piperidino)-butyrophenone. Part IV. Influence of haloperidol (R 1625) and of chlorpromazine on the behaviour of rats in an unfamiliar "open field" situation. Psychopharmacologia 1960; 1:389-92
8. Divry P, Bobon J, Collard J, Le R: 1625: nouvelle thérapeutique symptomatique de l'agitation psychomotrice. Acta Neurol Psychiatr Belg 1958; 58(10):878-88
9. Divry P, Bobon J, Collard J, Pinchard A, Nois E: Etude et expérimentations cliniques du R 1625 ou halopéridol, nouveau neuroleptique et "neurodysleptique". Acta Neurol Psychiatr Belg 1959; 59:337-66
10. Divry P., Bobon J., Collard J: Rapport sur l'activité neuropsychopharmacologique du haloperidol (R 1625). Acta Neurol Psychiatr Belg 1960; 60:7-19
11. Delay J, Pichot P, Lempérière T, Elissalde B: L'action de l'halopéridol dans les psychoses. Acta Neurol Psychiatr Belg 1960; 60:21-38
12. Delay J, Pichot P, Lempérière T, Elissalde B, Peigné F: Un neuroleptique majeur non phénothiazinique et non réserpinique, l'halopéridol dans le traitement des psychoses. Ann Med Psychol 1960; 118:145-152
13. Delay J, Pichot P, Lempérière T, Elissalde B: Halopéridol et chimiothérapie des psychoses. Presse Med 1960; 68:1353-1355
14. Denber HC, Rajotte P, Kauffman D: Problems in evaluation of R 1625. Am J Psychiatry 1959; 116:356-7